COR vs NVS
Cencora vs Novartis AG — AI-powered side-by-side comparison
| Metric | COR | NVS |
|---|---|---|
| AI Score | 68 | 71 |
| Price | $317.10 | $154.44 |
| P/E Ratio | 23.46× | 23.58× |
| ROE | 103.1% | 30.5% |
| Revenue Growth YoY | — | — |
| Gross Margin | 3.7% | 74.3% |
| Debt / Equity | 3.84× | 1.18× |
| Dividend Yield | 0.7% | 2.9% |
| RSI (14) | 63.5 | 46.9 |
| Beta | 0.581 | 0.46 |
| Expected Upside | +18.8% | +1.2% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
COR Full Analysis
NVS Full Analysis